Navigation Links
REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis
Date:9/23/2011

ients had failed to respond to or tolerate treatment with 6-mercaptopurine, azathioprine, corticosteroids and/or 5-aminosalicylates.  Patients received REMICADE® 5 mg/kg at weeks 0, 2, and 6.  The primary endpoint, clinical response at week 8, was defined as a decrease from baseline in the Mayo score of at least 30 percent and at least 3 points, with a decrease in rectal bleeding subscore of at least 1 or a rectal bleeding subscore of 0/1.  Patients who achieved clinical response at week 8 were randomized to receive REMICADE® 5 mg/kg every 8 weeks through week 46 or every 12 weeks through week 42.  Non-responders were discontinued from study agent.  

Safety data from the pediatric UC trial were consistent with current REMICADE® labeling.  No new safety concerns emerged in evaluating REMICADE® in the treatment of a pediatric UC population.

For more information regarding the safety profile for REMICADE®, please see "Important Safety Information" below.  

About Ulcerative Colitis

Ulcerative colitis (UC) is a chronic IBD of the colon.  It is estimated that 1.4 million Americans have IBD with the number evenly split between UC and Crohn's disease.  An estimated 150,000 children under age 17 are living with debilitating symptoms of IBD.(1)  

About REMICADE®

REMICADE® was the first anti-TNF-alpha treatment approved in the United States in August 1998 and the first TNF inhibitor to be approved in three different therapeutic areas: gastroenterology, rheumatology and dermatology.  REMICADE® has demonstrated broad clinical utility with indications in Crohn's disease, rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, ulcerative colitis (UC), pediatric Crohn's disease, psoriasis, and pediatric UC.  The safety and efficacy of REMICADE® have been well established in clinical trials over
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement
2. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
3. FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of Pediatric Ulcerative Colitis
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
8. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
9. CryoCor Receives FDA Approval for Right Atrial Flutter
10. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
11. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 22, 2014  Dr. Mark Rasak , MD ... Lifetime Achievement Award in the field of Medicine as ... Clinical Associates. Dr. Rasak has over 15 ... aspects of the business; overseeing the daily operations; interventional ... intervention. In addition, he is an honored Fellow of ...
(Date:8/22/2014)... Research and Markets has announced the addition ... Report 2014" report to their offering. ... 2014 is a professional and in-depth study on the ... a focus on the Chinese situation. The report ... classifications, applications and industry chain structure. The intravenous catheter ...
(Date:8/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. The ... definitions, classifications, applications and industry chain structure. The particulate ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Global and Chinese Intravenous Catheter Industry Report 2014 2Global and Chinese Particulate Respirators Industry Report 2014 2
... Ind., Aug. 18, 2011 Symmetry Medical Inc. (NYSE: ... innovative medical device solutions, including orthopedic implants, surgical instruments, ... has completed the previously announced acquisition of Olsen Medical. ... in the design, development and manufacturing of electrosurgical instruments ...
... 18, 2011 According to the Arthritis ... in the United States and is one of the ... Pet owners can easily be overwhelmed by the variety ... symptoms. NationalPetPharmacy.com provides the following nutritional recommendations ...
Cached Medicine Technology:Symmetry Medical Closes Olsen Medical Acquisition 2Tips for Reducing the Signs of Arthritis in Pets 2Tips for Reducing the Signs of Arthritis in Pets 3
(Date:8/22/2014)... HealthDay Reporter FRIDAY, Aug. ... Americans on work disability chronically use powerful prescription painkillers, ... between 2007 and 2011, about 44 percent of people ... painkillers each year. And the percentage using the drugs ... percent in 2011. Experts said the trend ...
(Date:8/22/2014)... 22, 2014 Millennium Treatment Group, ... Lantana, FL, recently launched a new website. Patients, ... information can now find Millennium Treatment Group at ... went live at the beginning of July. Everything ... can be found on the website. There’s an ...
(Date:8/22/2014)... oncogenic somatic mutation at amino acid 918 in the ... small cell lung cancer (SCLC) tumors and enforced expression ... intracellular signaling and cell growth. , SCLC is a ... all lung cancers and is strongly associated with tobacco ... extensively examined for genomic alterations and targeted therapies are ...
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... more magnetic for some clinical applications due to ... of the emerging innovations in ultrasound, such as ... imaging, are expected to keep the market moving ... as increasing mobility can enhance not only the ...
(Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... the recent past, specifically in the developing world, has ... infection and the number of deaths due to AIDS ... are declining, the number of new patients becoming affected ... the conscious efforts being undertaken by all related organisations ...
Breaking Medicine News(10 mins):Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Millennium Treatment Group Has a New Website 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3
... greater impact on health than outdoor air quality, as ... indoors. Exposure to chemical and biological contaminants and possible ... risk of developing respiratory and neurologic symptoms, allergies, asthma ... of Ottawa; the Environmental Health Sciences Bureau (Canada); the ...
... make the habit more likely, study finds , , MONDAY, July ... easily on cigarettes -- say from friends or close acquaintances ... smoking habit, a new study of sixth-graders finds. , Hopefully, ... before they even start, said the authors of ...
... U.S. by 2050 , , MONDAY, July 14 (HealthDay News) -- ... boost kidney stone rates in the United States and around ... in particular, hotter weather will lead to a dramatic rise ... the so-called "kidney-stone belt." This will result in an increase ...
... Medical Device,Manufacturers Association (MDMA), a national trade association ... Board of Directors at the,MDMA Annual Meeting held ... ), "I am honored to serve ... stated Root. "MDMA has a long history of ...
... Nets star Josh Boone and 50 local students, WHAT: To ... program, the Nets will conduct a fitness clinic to encourage ... drinking milk, ... Josh Boone,s week long basketball camp., WHY: ...
... report lower quality of life, poorer outlook , , MONDAY, July ... a person,s outlook on life, a new government study finds. ... lower on four scales measuring their quality of life, according ... Circulation , from researchers at the U.S. Centers for Disease ...
Cached Medicine News:Health News:Access Is Key to Kids' Decision to Smoke 2Health News:Global Warming Linked to Heightened Kidney Stone Risk 2Health News:Global Warming Linked to Heightened Kidney Stone Risk 3Health News:Vascular Solutions CEO Elected to MDMA Board of Directors 2Health News:Coronary Heart Disease Not a Cheery Condition 2Health News:Coronary Heart Disease Not a Cheery Condition 3
... For use in the percutaneous retrieval of indwelling ... wire guides, and other foreign objects. A ... around the lead body. It is delivered to ... flexible 12 Fr cannula that is placed coaxially ...
... Novalis, BrainLAB's dedicated ... radiosurgery and radiotherapy (SRS/SRT), ... highly precise treatments of ... head & neck tumors, ...
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: